In Brief: Sanofi
Executive Summary
Sanofi: George Clay, PhD, to VP-regulatory affairs of Sanofi, Inc., reporting to Chief Operating Officer Philippe Le Goff, and VP-drug regulatory affairs of Sanofi Winthrop, reporting to Sanofi Winthrop CEO George Doherty. Clay, who was most recently senior VP-regulatory affairs for Novo Nordisk, started work at Sanofi in mid-March...